Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

L M Itri

Showing results (41-50 of 45) with videos related to

Pageof 5
Sort By:
You have reached the last page of results.This site can display upto 45 results.
Journal of Immunotherapy : Official Journal of the Society for Biological Therapy|February 1, 1991
Interferon-alpha 2a in the treatment of acquired immunodeficiency syndrome-related Kaposi's sarcomaL M Evans, L M Itri, M Campion, et al.
The New England Journal of Medicine|September 20, 1990
Prevention of second primary tumors with isotretinoin in squamous-cell carcinoma of the head and neckW K Hong, S M Lippman, L M Itri, et al.
Journal of the National Cancer Institute|February 19, 1992
13-cis-retinoic acid and interferon alpha-2a: effective combination therapy for advanced squamous cell carcinoma of the skinS M Lippman, D R Parkinson, L M Itri, et al.
The Oncologist|October 21, 2000
Impact of cancer-related fatigue on the lives of patients: new findings from the Fatigue CoalitionG A Curt, W Breitbart, D Cella, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|June 11, 2021
Biomarker analyses in the phase III ASCENT study of sacituzumab govitecan versus chemotherapy in patients with metastatic triple-negative breast cancerA Bardia, S M Tolaney, K Punie, et al.
Pageof 5

Showing results (41-50 of 45) with videos related to

Sort By:
Pageof 5
You have reached the last page of results.This site can display upto 45 results.
Journal of Immunotherapy : Official Journal of the Society for Biological Therapy|February 1, 1991
Interferon-alpha 2a in the treatment of acquired immunodeficiency syndrome-related Kaposi's sarcomaL M Evans, L M Itri, M Campion, et al.
The New England Journal of Medicine|September 20, 1990
Prevention of second primary tumors with isotretinoin in squamous-cell carcinoma of the head and neckW K Hong, S M Lippman, L M Itri, et al.
Journal of the National Cancer Institute|February 19, 1992
13-cis-retinoic acid and interferon alpha-2a: effective combination therapy for advanced squamous cell carcinoma of the skinS M Lippman, D R Parkinson, L M Itri, et al.
The Oncologist|October 21, 2000
Impact of cancer-related fatigue on the lives of patients: new findings from the Fatigue CoalitionG A Curt, W Breitbart, D Cella, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|June 11, 2021
Biomarker analyses in the phase III ASCENT study of sacituzumab govitecan versus chemotherapy in patients with metastatic triple-negative breast cancerA Bardia, S M Tolaney, K Punie, et al.
Pageof 5